272 related articles for article (PubMed ID: 26692368)
1. Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis.
de Bruin NM; Schmitz K; Schiffmann S; Tafferner N; Schmidt M; Jordan H; Häußler A; Tegeder I; Geisslinger G; Parnham MJ
Behav Brain Res; 2016 Mar; 300():160-74. PubMed ID: 26692368
[TBL] [Abstract][Full Text] [Related]
2. FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses.
Papadopoulos D; Rundle J; Patel R; Marshall I; Stretton J; Eaton R; Richardson JC; Gonzalez MI; Philpott KL; Reynolds R
J Neurosci Res; 2010 Feb; 88(2):346-59. PubMed ID: 19658199
[TBL] [Abstract][Full Text] [Related]
3. Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations.
Sheridan GK; Dev KK
Sci Rep; 2014 May; 4():5051. PubMed ID: 24851861
[TBL] [Abstract][Full Text] [Related]
4. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation.
Tsai HC; Huang Y; Garris CS; Moreno MA; Griffin CW; Han MH
JCI Insight; 2016 Jun; 1(9):e86462. PubMed ID: 27699272
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior.
Kocovski P; Tabassum-Sheikh N; Marinis S; Dang PT; Hale MW; Orian JM
Front Immunol; 2021; 12():639650. PubMed ID: 34177891
[TBL] [Abstract][Full Text] [Related]
6. Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis.
Chiba K; Kataoka H; Seki N; Shimano K; Koyama M; Fukunari A; Sugahara K; Sugita T
Int Immunopharmacol; 2011 Mar; 11(3):366-72. PubMed ID: 20955831
[TBL] [Abstract][Full Text] [Related]
7. Novel Zebrafish EAE model: A quick in vivo screen for multiple sclerosis.
Kulkarni P; Yellanki S; Medishetti R; Sriram D; Saxena U; Yogeeswari P
Mult Scler Relat Disord; 2017 Jan; 11():32-39. PubMed ID: 28104252
[TBL] [Abstract][Full Text] [Related]
8. FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration.
Kataoka H; Sugahara K; Shimano K; Teshima K; Koyama M; Fukunari A; Chiba K
Cell Mol Immunol; 2005 Dec; 2(6):439-48. PubMed ID: 16426494
[TBL] [Abstract][Full Text] [Related]
9. Dimethyl fumarate modulates the regulatory T cell response in the mesenteric lymph nodes of mice with experimental autoimmune encephalomyelitis.
Lima ADR; Ferrari BB; Pradella F; Carvalho RM; Rivero SLS; Quintiliano RPS; Souza MA; Brunetti NS; Marques AM; Santos IP; Farias AS; Oliveira EC; Santos LMB
Front Immunol; 2024; 15():1391949. PubMed ID: 38765015
[TBL] [Abstract][Full Text] [Related]
10. Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice.
Imeri F; Fallegger D; Zivkovic A; Schwalm S; Enzmann G; Blankenbach K; Meyer zu Heringdorf D; Homann T; Kleuser B; Pfeilschifter J; Engelhardt B; Stark H; Huwiler A
Neuropharmacology; 2014 Oct; 85():314-27. PubMed ID: 24863045
[TBL] [Abstract][Full Text] [Related]
11. Diffusion tensor imaging detects treatment effects of FTY720 in experimental autoimmune encephalomyelitis mice.
Wang X; Brieland JK; Kim JH; Chen YJ; O'Neal J; O'Neil SP; Tu TW; Trinkaus K; Song SK
NMR Biomed; 2013 Dec; 26(12):1742-50. PubMed ID: 23939596
[TBL] [Abstract][Full Text] [Related]
12. Specific and strain-independent effects of dexamethasone in the prevention and treatment of experimental autoimmune encephalomyelitis in rodents.
Donia M; Mangano K; Quattrocchi C; Fagone P; Signorelli S; Magro G; Sfacteria A; Bendtzen K; Nicoletti F
Scand J Immunol; 2010 Nov; 72(5):396-407. PubMed ID: 21039734
[TBL] [Abstract][Full Text] [Related]
13. AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
Samuvel DJ; Saxena N; Dhindsa JS; Singh AK; Gill GS; Grobelny DW; Singh I
PLoS One; 2015; 10(10):e0141781. PubMed ID: 26513477
[TBL] [Abstract][Full Text] [Related]
14. Fingolimod attenuates gait deficits in mice subjected to experimental autoimmune encephalomyelitis.
Kasheke GDS; Holman SP; Robertson GS
J Neuroimmunol; 2022 Sep; 370():577926. PubMed ID: 35863299
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis.
Bail K; Notz Q; Rovituso DM; Schampel A; Wunsch M; Koeniger T; Schropp V; Bharti R; Scholz CJ; Foerstner KU; Kleinschnitz C; Kuerten S
J Neuroinflammation; 2017 Jul; 14(1):148. PubMed ID: 28738885
[TBL] [Abstract][Full Text] [Related]
16. The effect of omeprazole on the development of experimental autoimmune encephalomyelitis in C57BL/6J and SJL/J mice.
Sands SA; Tsau S; Yankee TM; Parker BL; Ericsson AC; LeVine SM
BMC Res Notes; 2014 Sep; 7():605. PubMed ID: 25190469
[TBL] [Abstract][Full Text] [Related]
17. Kinematic gait parameters are highly sensitive measures of motor deficits and spinal cord injury in mice subjected to experimental autoimmune encephalomyelitis.
Fiander MD; Stifani N; Nichols M; Akay T; Robertson GS
Behav Brain Res; 2017 Jan; 317():95-108. PubMed ID: 27639322
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine kinase 2 deficient mice exhibit reduced experimental autoimmune encephalomyelitis: Resistance to FTY720 but not ST-968 treatments.
Imeri F; Schwalm S; Lyck R; Zivkovic A; Stark H; Engelhardt B; Pfeilschifter J; Huwiler A
Neuropharmacology; 2016 Jun; 105():341-350. PubMed ID: 26808312
[TBL] [Abstract][Full Text] [Related]
19. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis.
Hammer LA; Zagon IS; McLaughlin PJ
Brain Res Bull; 2015 Mar; 112():42-51. PubMed ID: 25647234
[TBL] [Abstract][Full Text] [Related]
20. Inhalation of dimethyl fumarate-encapsulated solid lipid nanoparticles attenuate clinical signs of experimental autoimmune encephalomyelitis and pulmonary inflammatory dysfunction in mice.
Pinto BF; Ribeiro LNB; da Silva GBRF; Freitas CS; Kraemer L; Oliveira FMS; Clímaco MC; Mourão FAG; Santos GSPD; Béla SR; Gurgel ILDS; Leite FL; de Oliveira AG; Vilela MRSDP; Oliveira-Lima OC; Soriani FM; Fujiwara RT; Birbrair A; Russo RC; Carvalho-Tavares J
Clin Sci (Lond); 2022 Jan; 136(1):81-101. PubMed ID: 34904644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
